Professional Documents
Culture Documents
Parenteral Medication
Parenteral Medication
L
MEDICATION
Assessment
Injection site
Drug allergies
Patient condition –
be alert to changes
that can affect drug
therapy
Consent forms
Parenteral
Administration
Parenteral Medications are given through a route
other than the alimentary canal; these routes are:
Intradermal (ID)
Subcutaneous (SC or SQ)
Intramuscular (IM)
Intravenous ( IV)
EQUIPMENT
Needles
Available in different gauges – the
smaller
the number, the larger the gauge
(inside diameter)
Length – long enough to penetrate the
appropriate layers of tissue
Syringes
Barrel
Plunger
With or without needle
Needles
A needle has three parts, the hub, the shaft, and the bevel.
The hub is at one end of the needle and is the
part that attaches to the syringe.
Given at a 45-degree
angle
25- or 26-gauge needle, 3/8 to 5/8
inch length
No more then 1.5 mL
should be injected into the
site
to avoid pressure on
sensory
nerves causing pain and
discomfort
Subcutaneous Injections
For children and some adults, IM injections are given into the
deltoid muscles of the shoulders
Intramuscular Injections
Used to administer
antibiotics
vitamins
iron
vaccines
Absorption of drug by IM route is unpredictable
not recommended for patients who are unconscious or in a
shocklike state
Parenteral Administration
Intramuscular Injection
Promote rapid drug absorption.
Provide an alternate route when drug is irritating
to subcutaneous tissue.
Sites
Gauge and needle length
30-52
Intravenous Injections or Infusions
Intravenous (IV) injections are administered at
a 15- to 20-degree angle
Parenteral Dose Forms
Subcutaneous injections
under the skin
Commonly used
for fluid and electrolyte replacement
to provide necessary nutrition to the patient who is critically ill
Assessments Prior to Injection Administration
Sample Documentation
Patient reports post-surgical pain at a level of 8/10. Patient is
grimacing when moving in the bed and describes pain as a dull
constant ache located in the right lower abdomen surgical
incision area that is aggravated by moving or repositioning.
Blood pressure 146/80, heart rate 94 bpm, respirations 22 per
minute, temperature (tympanic) 98.8°F, pulse oximetry 98%.
Last pain medication Ketorolac 30 mg (IM) given 8 hours ago.
Incision site is dry and intact. Ketorolac 30mg IM administered
per health provider’s prescription in the left ventrogluteal area
with 22-gauge needle, length 1 ½ inches. Patient tolerated the
procedure without difficulty or increased pain. Injection site
post-procedure without bleeding or hematoma.